Moderate  ||| S:0 E:9 ||| JJ
and  ||| S:9 E:13 ||| CC
high  ||| S:13 E:18 ||| JJ
intensity  ||| S:18 E:28 ||| NN
sprint  ||| S:28 E:35 ||| NNS
exercise  ||| S:35 E:44 ||| VBP
induce  ||| S:44 E:51 ||| JJ
differential  ||| S:51 E:64 ||| NN
responses  ||| S:64 E:74 ||| NNS
in  ||| S:74 E:77 ||| IN
COX4I2  ||| S:77 E:84 ||| NNP
and  ||| S:84 E:88 ||| CC
PDK4  ||| S:88 E:93 ||| CD
gene  ||| S:93 E:98 ||| NN
expression  ||| S:98 E:109 ||| NN
in  ||| S:109 E:112 ||| IN
Thoroughbred  ||| S:112 E:125 ||| NNP
horse  ||| S:125 E:131 ||| NN
skeletal  ||| S:131 E:140 ||| NNS
muscle  ||| S:140 E:147 ||| VBP
The  ||| S:147 E:151 ||| DT
role  ||| S:151 E:156 ||| NN
of  ||| S:156 E:159 ||| IN
molecular  ||| S:159 E:169 ||| JJ
signalling  ||| S:169 E:180 ||| JJ
pathways  ||| S:180 E:189 ||| NN
in  ||| S:189 E:192 ||| IN
the  ||| S:192 E:196 ||| DT
phenotypic  ||| S:196 E:207 ||| JJ
adaptation  ||| S:207 E:218 ||| NN
of  ||| S:218 E:221 ||| IN
skeletal  ||| S:221 E:230 ||| JJ
muscle  ||| S:230 E:237 ||| NN
to  ||| S:237 E:240 ||| TO
different  ||| S:240 E:250 ||| JJ
exercise  ||| S:250 E:259 ||| NN
stimuli  ||| S:259 E:267 ||| NNS
in  ||| S:267 E:270 ||| IN
the  ||| S:270 E:274 ||| DT
Thoroughbred  ||| S:274 E:287 ||| JJ
horse  ||| S:287 E:293 ||| NN
has  ||| S:293 E:297 ||| VBZ
not  ||| S:297 E:301 ||| RB
been  ||| S:301 E:306 ||| VBN
reported  ||| S:306 E:315 ||| VBN
previously ||| S:315 E:325 ||| RB
.  ||| S:325 E:327 ||| .
To  ||| S:327 E:330 ||| TO
examine  ||| S:330 E:338 ||| VB
CKM ||| S:338 E:341 ||| NNP
,  ||| S:341 E:343 ||| ,
COX4I1 ||| S:343 E:349 ||| NNP
,  ||| S:349 E:351 ||| ,
COX4I2  ||| S:351 E:358 ||| NNP
and  ||| S:358 E:362 ||| CC
PDK4  ||| S:362 E:367 ||| CD
gene  ||| S:367 E:372 ||| NN
expression  ||| S:372 E:383 ||| NN
following  ||| S:383 E:393 ||| VBG
high  ||| S:393 E:398 ||| JJ
intensity  ||| S:398 E:408 ||| NN
sprint  ||| S:408 E:415 ||| NNS
and  ||| S:415 E:419 ||| CC
moderate  ||| S:419 E:428 ||| JJ
intensity  ||| S:428 E:438 ||| NN
treadmill  ||| S:438 E:448 ||| NN
exercise  ||| S:448 E:457 ||| NN
stimuli  ||| S:457 E:465 ||| NNS
in  ||| S:465 E:468 ||| IN
skeletal  ||| S:468 E:477 ||| JJ
muscle  ||| S:477 E:484 ||| NN
of  ||| S:484 E:487 ||| IN
Thoroughbred  ||| S:487 E:500 ||| NNP
horses ||| S:500 E:506 ||| NNS
.  ||| S:506 E:508 ||| .
Two  ||| S:508 E:512 ||| CD
groups  ||| S:512 E:519 ||| NNS
of  ||| S:519 E:522 ||| IN
trained  ||| S:522 E:530 ||| JJ
3-year-old  ||| S:530 E:541 ||| NNP
Thoroughbred  ||| S:541 E:554 ||| NNP
horses  ||| S:554 E:561 ||| NNS
participated ||| S:561 E:573 ||| VBD
.  ||| S:573 E:575 ||| .
Group  ||| S:575 E:581 ||| NNP
A  ||| S:581 E:583 ||| NNP
( ||| S:583 E:584 ||| -LRB-
n  ||| S:584 E:586 ||| CD
=  ||| S:586 E:588 ||| SYM
6  ||| S:588 E:590 ||| CD
females ||| S:590 E:597 ||| NNS
,  ||| S:597 E:599 ||| ,
n  ||| S:599 E:601 ||| VBG
=  ||| S:601 E:603 ||| SYM
3  ||| S:603 E:605 ||| CD
males ||| S:605 E:610 ||| NNS
)  ||| S:610 E:612 ||| -RRB-
participated  ||| S:612 E:625 ||| VBD
in  ||| S:625 E:628 ||| IN
an  ||| S:628 E:631 ||| DT
incremental  ||| S:631 E:643 ||| JJ
step  ||| S:643 E:648 ||| NN
test  ||| S:648 E:653 ||| NN
( ||| S:653 E:654 ||| -LRB-
moderate  ||| S:654 E:663 ||| JJ
intensity ||| S:663 E:672 ||| NN
)  ||| S:672 E:674 ||| -RRB-
to  ||| S:674 E:677 ||| TO
fatigue  ||| S:677 E:685 ||| VB
or  ||| S:685 E:688 ||| CC
HR ||| S:688 E:690 ||| NNP
( ||| S:690 E:691 ||| -LRB-
max ||| S:691 E:694 ||| LS
)  ||| S:694 E:696 ||| -RRB-
on  ||| S:696 E:699 ||| IN
a  ||| S:699 E:701 ||| DT
Sato  ||| S:701 E:706 ||| JJ
high  ||| S:706 E:711 ||| JJ
speed  ||| S:711 E:717 ||| NN
treadmill  ||| S:717 E:727 ||| NNS
( ||| S:727 E:728 ||| -LRB-
distance  ||| S:728 E:737 ||| NN
=  ||| S:737 E:739 ||| SYM
5418.67  ||| S:739 E:747 ||| FW
m  ||| S:747 E:749 ||| FW
±  ||| S:749 E:751 ||| FW
343.21 ||| S:751 E:757 ||| FW
) ||| S:757 E:758 ||| -RRB-
.  ||| S:758 E:760 ||| .
Group  ||| S:760 E:766 ||| NNP
B  ||| S:766 E:768 ||| NNP
( ||| S:768 E:769 ||| -LRB-
n  ||| S:769 E:771 ||| CD
=  ||| S:771 E:773 ||| SYM
8  ||| S:773 E:775 ||| CD
females ||| S:775 E:782 ||| NNS
)  ||| S:782 E:784 ||| -RRB-
participated  ||| S:784 E:797 ||| VBD
in  ||| S:797 E:800 ||| IN
routine  ||| S:800 E:808 ||| NN
' ||| S:808 E:809 ||| POS
work ||| S:809 E:813 ||| NN
'  ||| S:813 E:815 ||| ''
( ||| S:815 E:816 ||| -LRB-
sprint ||| S:816 E:822 ||| LS
)  ||| S:822 E:824 ||| -RRB-
on  ||| S:824 E:827 ||| IN
an  ||| S:827 E:830 ||| DT
all-weather  ||| S:830 E:842 ||| JJ
gallop  ||| S:842 E:849 ||| NNS
( ||| S:849 E:850 ||| -LRB-
distance  ||| S:850 E:859 ||| NN
=  ||| S:859 E:861 ||| SYM
812.83  ||| S:861 E:868 ||| FW
m  ||| S:868 E:870 ||| FW
±  ||| S:870 E:872 ||| FW
12.53 ||| S:872 E:877 ||| FW
) ||| S:877 E:878 ||| -RRB-
.  ||| S:878 E:880 ||| .
Biopsy  ||| S:880 E:887 ||| JJ
samples  ||| S:887 E:895 ||| NNS
were  ||| S:895 E:900 ||| VBD
obtained  ||| S:900 E:909 ||| VBN
from  ||| S:909 E:914 ||| IN
the  ||| S:914 E:918 ||| DT
gluteus  ||| S:918 E:926 ||| FW
medius  ||| S:926 E:933 ||| FW
pre-exercise  ||| S:933 E:946 ||| FW
( ||| S:946 E:947 ||| -LRB-
T ||| S:947 E:948 ||| NNP
( ||| S:948 E:949 ||| -LRB-
0 ||| S:949 E:950 ||| LS
) ||| S:950 E:951 ||| -RRB-
) ||| S:951 E:952 ||| -RRB-
,  ||| S:952 E:954 ||| ,
immediately  ||| S:954 E:966 ||| RB
post  ||| S:966 E:971 ||| VB
exercise  ||| S:971 E:980 ||| NN
( ||| S:980 E:981 ||| -LRB-
T ||| S:981 E:982 ||| NNP
( ||| S:982 E:983 ||| -LRB-
1 ||| S:983 E:984 ||| LS
) ||| S:984 E:985 ||| -RRB-
)  ||| S:985 E:987 ||| -RRB-
and  ||| S:987 E:991 ||| CC
4  ||| S:991 E:993 ||| CD
h  ||| S:993 E:995 ||| JJ
post  ||| S:995 E:1000 ||| NN
exercise  ||| S:1000 E:1009 ||| NN
( ||| S:1009 E:1010 ||| -LRB-
T ||| S:1010 E:1011 ||| NNP
( ||| S:1011 E:1012 ||| -LRB-
2 ||| S:1012 E:1013 ||| LS
) ||| S:1013 E:1014 ||| -RRB-
) ||| S:1014 E:1015 ||| -RRB-
.  ||| S:1015 E:1017 ||| .
For  ||| S:1017 E:1021 ||| IN
physiological  ||| S:1021 E:1035 ||| JJ
relevance  ||| S:1035 E:1045 ||| NN
venous  ||| S:1045 E:1052 ||| NN
blood  ||| S:1052 E:1058 ||| NN
samples  ||| S:1058 E:1066 ||| NNS
were  ||| S:1066 E:1071 ||| VBD
collected  ||| S:1071 E:1081 ||| VBN
to  ||| S:1081 E:1084 ||| TO
measure  ||| S:1084 E:1092 ||| VB
plasma  ||| S:1092 E:1099 ||| JJ
lactate  ||| S:1099 E:1107 ||| NN
and  ||| S:1107 E:1111 ||| CC
creatine  ||| S:1111 E:1120 ||| JJ
kinase  ||| S:1120 E:1127 ||| JJ
concentrations ||| S:1127 E:1141 ||| NNS
.  ||| S:1141 E:1143 ||| .
Changes  ||| S:1143 E:1151 ||| NNS
in  ||| S:1151 E:1154 ||| IN
mRNA  ||| S:1154 E:1159 ||| JJ
expression  ||| S:1159 E:1170 ||| NN
were  ||| S:1170 E:1175 ||| VBD
determined  ||| S:1175 E:1186 ||| VBN
by  ||| S:1186 E:1189 ||| IN
quantitative  ||| S:1189 E:1202 ||| JJ
real-time  ||| S:1202 E:1212 ||| JJ
RT-PCR  ||| S:1212 E:1219 ||| NN
for  ||| S:1219 E:1223 ||| IN
creatine  ||| S:1223 E:1232 ||| JJ
kinase  ||| S:1232 E:1239 ||| JJ
muscle  ||| S:1239 E:1246 ||| NN
( ||| S:1246 E:1247 ||| -LRB-
CKM ||| S:1247 E:1250 ||| NNP
) ||| S:1250 E:1251 ||| -RRB-
,  ||| S:1251 E:1253 ||| ,
cytochrome  ||| S:1253 E:1264 ||| VBG
c  ||| S:1264 E:1266 ||| SYM
oxidase  ||| S:1266 E:1274 ||| FW
subunit  ||| S:1274 E:1282 ||| FW
IV  ||| S:1282 E:1285 ||| NNP
isoform  ||| S:1285 E:1293 ||| VBD
1  ||| S:1293 E:1295 ||| CD
( ||| S:1295 E:1296 ||| -LRB-
COX4I1 ||| S:1296 E:1302 ||| NNP
) ||| S:1302 E:1303 ||| -RRB-
,  ||| S:1303 E:1305 ||| ,
cytochrome  ||| S:1305 E:1316 ||| VBG
c  ||| S:1316 E:1318 ||| SYM
oxidase  ||| S:1318 E:1326 ||| FW
subunit  ||| S:1326 E:1334 ||| FW
IV  ||| S:1334 E:1337 ||| NNP
isoform  ||| S:1337 E:1345 ||| VBD
2  ||| S:1345 E:1347 ||| CD
( ||| S:1347 E:1348 ||| -LRB-
COX4I2 ||| S:1348 E:1354 ||| NNP
)  ||| S:1354 E:1356 ||| -RRB-
and  ||| S:1356 E:1360 ||| CC
pyruvate  ||| S:1360 E:1369 ||| JJ
dehydrogenase  ||| S:1369 E:1383 ||| JJ
kinase ||| S:1383 E:1389 ||| NN
,  ||| S:1389 E:1391 ||| ,
isozyme  ||| S:1391 E:1399 ||| CD
4  ||| S:1399 E:1401 ||| CD
( ||| S:1401 E:1402 ||| -LRB-
PDK4 ||| S:1402 E:1406 ||| NNP
)  ||| S:1406 E:1408 ||| -RRB-
genes ||| S:1408 E:1413 ||| NNS
.  ||| S:1413 E:1415 ||| .
Statistical  ||| S:1415 E:1427 ||| JJ
significance  ||| S:1427 E:1440 ||| NN
( ||| S:1440 E:1441 ||| -LRB-
α  ||| S:1441 E:1443 ||| CD
< ||| S:1443 E:1445 ||| SYM
0.05 ||| S:1445 E:1449 ||| CD
)  ||| S:1449 E:1451 ||| -RRB-
was  ||| S:1451 E:1455 ||| VBD
determined  ||| S:1455 E:1466 ||| VBN
using  ||| S:1466 E:1472 ||| VBG
Student ||| S:1472 E:1479 ||| NNP
's  ||| S:1479 E:1482 ||| POS
t  ||| S:1482 E:1484 ||| JJ
tests ||| S:1484 E:1489 ||| NNS
.  ||| S:1489 E:1491 ||| .
COX4I2  ||| S:1491 E:1498 ||| NNP
mRNA  ||| S:1498 E:1503 ||| JJ
expression  ||| S:1503 E:1514 ||| NN
decreased  ||| S:1514 E:1524 ||| VBD
significantly  ||| S:1524 E:1538 ||| RB
in  ||| S:1538 E:1541 ||| IN
Group  ||| S:1541 E:1547 ||| NNP
A  ||| S:1547 E:1549 ||| NNP
and  ||| S:1549 E:1553 ||| CC
remained  ||| S:1553 E:1562 ||| VBD
unchanged  ||| S:1562 E:1572 ||| JJ
in  ||| S:1572 E:1575 ||| IN
Group  ||| S:1575 E:1581 ||| NNP
B  ||| S:1581 E:1583 ||| NNP
between  ||| S:1583 E:1591 ||| IN
T ||| S:1591 E:1592 ||| NN
( ||| S:1592 E:1593 ||| -LRB-
0 ||| S:1593 E:1594 ||| LS
)  ||| S:1594 E:1596 ||| -RRB-
vs.  ||| S:1596 E:1600 ||| FW
T ||| S:1600 E:1601 ||| FW
( ||| S:1601 E:1602 ||| -LRB-
2 ||| S:1602 E:1603 ||| LS
)  ||| S:1603 E:1605 ||| -RRB-
( ||| S:1605 E:1606 ||| -LRB-
-1.7-fold ||| S:1606 E:1615 ||| NNP
,  ||| S:1615 E:1617 ||| ,
P  ||| S:1617 E:1619 ||| NN
=  ||| S:1619 E:1621 ||| SYM
0.017 ||| S:1621 E:1626 ||| CD
;  ||| S:1626 E:1628 ||| :
-1.0-fold ||| S:1628 E:1637 ||| CD
,  ||| S:1637 E:1639 ||| ,
P  ||| S:1639 E:1641 ||| NN
=  ||| S:1641 E:1643 ||| SYM
0.859 ||| S:1643 E:1648 ||| CD
) ||| S:1648 E:1649 ||| -RRB-
.  ||| S:1649 E:1651 ||| .
PDK4  ||| S:1651 E:1656 ||| NNP
mRNA  ||| S:1656 E:1661 ||| JJ
expression  ||| S:1661 E:1672 ||| NN
increased  ||| S:1672 E:1682 ||| VBD
significantly  ||| S:1682 E:1696 ||| RB
in  ||| S:1696 E:1699 ||| IN
Group  ||| S:1699 E:1705 ||| NNP
B  ||| S:1705 E:1707 ||| NNP
but  ||| S:1707 E:1711 ||| CC
not  ||| S:1711 E:1715 ||| RB
in  ||| S:1715 E:1718 ||| IN
Group  ||| S:1718 E:1724 ||| NNP
A  ||| S:1724 E:1726 ||| NNP
between  ||| S:1726 E:1734 ||| IN
T ||| S:1734 E:1735 ||| NN
( ||| S:1735 E:1736 ||| -LRB-
0 ||| S:1736 E:1737 ||| LS
)  ||| S:1737 E:1739 ||| -RRB-
vs.  ||| S:1739 E:1743 ||| FW
T ||| S:1743 E:1744 ||| FW
( ||| S:1744 E:1745 ||| -LRB-
1 ||| S:1745 E:1746 ||| LS
)  ||| S:1746 E:1748 ||| -RRB-
( ||| S:1748 E:1749 ||| -LRB-
3.8-fold ||| S:1749 E:1757 ||| NNP
,  ||| S:1757 E:1759 ||| ,
P  ||| S:1759 E:1761 ||| NN
=  ||| S:1761 E:1763 ||| SYM
0.039 ||| S:1763 E:1768 ||| CD
;  ||| S:1768 E:1770 ||| :
1.4-fold ||| S:1770 E:1778 ||| CD
,  ||| S:1778 E:1780 ||| ,
P  ||| S:1780 E:1782 ||| NN
=  ||| S:1782 E:1784 ||| SYM
0.591 ||| S:1784 E:1789 ||| CD
) ||| S:1789 E:1790 ||| -RRB-
.  ||| S:1790 E:1792 ||| .
There  ||| S:1792 E:1798 ||| EX
were  ||| S:1798 E:1803 ||| VBD
no  ||| S:1803 E:1806 ||| DT
significant  ||| S:1806 E:1818 ||| JJ
changes  ||| S:1818 E:1826 ||| NNS
in  ||| S:1826 E:1829 ||| IN
the  ||| S:1829 E:1833 ||| DT
expression  ||| S:1833 E:1844 ||| NN
in  ||| S:1844 E:1847 ||| IN
CKM  ||| S:1847 E:1851 ||| NNP
or  ||| S:1851 E:1854 ||| CC
COX4I1  ||| S:1854 E:1861 ||| CD
mRNA  ||| S:1861 E:1866 ||| JJ
abundance  ||| S:1866 E:1876 ||| NN
in  ||| S:1876 E:1879 ||| IN
either  ||| S:1879 E:1886 ||| DT
group ||| S:1886 E:1891 ||| NN
.  ||| S:1891 E:1893 ||| .
Different  ||| S:1893 E:1903 ||| JJ
exercise  ||| S:1903 E:1912 ||| NN
protocols  ||| S:1912 E:1922 ||| NNS
elicit  ||| S:1922 E:1929 ||| VBP
variable  ||| S:1929 E:1938 ||| JJ
transcriptional  ||| S:1938 E:1954 ||| JJ
responses  ||| S:1954 E:1964 ||| NNS
in  ||| S:1964 E:1967 ||| IN
key  ||| S:1967 E:1971 ||| JJ
exercise  ||| S:1971 E:1980 ||| NN
relevant  ||| S:1980 E:1989 ||| JJ
genes  ||| S:1989 E:1995 ||| NNS
in  ||| S:1995 E:1998 ||| IN
equine  ||| S:1998 E:2005 ||| JJ
skeletal  ||| S:2005 E:2014 ||| JJ
muscle  ||| S:2014 E:2021 ||| NN
due  ||| S:2021 E:2025 ||| JJ
to  ||| S:2025 E:2028 ||| TO
variation  ||| S:2028 E:2038 ||| VB
in  ||| S:2038 E:2041 ||| IN
metabolic  ||| S:2041 E:2051 ||| JJ
demand ||| S:2051 E:2057 ||| NN
.  ||| S:2057 E:2059 ||| .
